MedThink SciCom’s Post

Hey Medical Affairs friends! How are you driving patient outcomes? It starts with your abiliy to drive scientific awareness using customer intelligence and cross-funtional - medical, commerical, clinical - workflows. Are you approching this challange with an enterprise-wide approach?

I stumbled upon this insight couple years ago in an event on the evolving landscape of medical affairs engagement, especially in light of the post pandemic's impact. While intriguing, I never had the time to fully delve into it. It's fascinating to see how the pharmaceutical industry is adapting, but I'm curious why other sectors haven't embraced similar insights. Link to the article: https://lnkd.in/gcHNdt4e Interested in exploring this further? Like this post for a deeper dive in my next newsletter. #FoodForThought #MedicalAffairs #PharmaceuticalIndustry #HCPengagement

Government and third-party organizations tightly regulate quality in medical, pharmaceutical and diagnostic device design, development and manufacturing. Certifications and registrations are the bare minimum of what’s required. For a quality commitment to be truly authentic and reliable, it must be all-encompassing and reflected in an organization’s vision, values, culture, employees, products and services. 🌟 Learn the three principles of the Phillips-Medisize secret sauce for quality success in our newest blog, “Building a Quality Culture to Improve Healthcare Manufacturing.”🌟 Read now: https://lnkd.in/g5Tx32G8 #QualityInManufacturing #MedicalDevices #QualityAssurance

Are you leading the charge in Medical Affairs within the pharmaceutical industry? Elevate your impact with our 'Advanced Medical Affairs for Country Medical Leaders' course. Perfect for Country Medical Directors and emerging leaders. Dive deeper into strategic leadership within the pharmaceutical landscape. Details here: 'Sky Health Academy Course - https://lnkd.in/d-yc6Rjd #pharmaceutical #MedicalAffairs #MedicalDirectors #SkyHealthAcademy

Are you leading the charge in Medical Affairs within the pharmaceutical industry? Elevate your impact with our 'Advanced Medical Affairs for Country Medical Leaders' course. Perfect for Country Medical Directors and emerging leaders. Dive deeper into strategic leadership within the pharmaceutical landscape. Details here: 'Sky Health Academy Course - https://lnkd.in/d-yc6Rjd #pharmaceutical #MedicalAffairs #MedicalDirectors #SkyHealthAcademy

A vision for medical affairs 2030: Five priorities for patient impact - McKinsey >>> lqventures.com #strategy #competitiveintelligence #marketing #pharmaceutical #biotech #pharma #competitivemarketing #healthcare

Are you leading the charge in Medical Affairs within the pharmaceutical industry? Elevate your impact with our 'Advanced Medical Affairs for Country Medical Leaders' course. Perfect for Country Medical Directors and emerging leaders. Dive deeper into strategic leadership within the pharmaceutical landscape. Details here: 'Sky Health Academy Course - https://lnkd.in/d-yc6Rjd #pharmaceutical #MedicalAffairs #MedicalDirectors #SkyHealthAcademy

New blog! Much has been written about the post-Pandemic recovery of interactive engagement between Pharmaceutical companies and healthcare professionals on a promotional basis, and the fact that only the US has exceeded pre-Pandemic levels of promotional interaction, but there's been less data on the level of non-promotional interaction between healthcare professionals and #medicalaffairs since the Pandemic's start. In this blog Markus Gores and Reinhard Berkels, PhD (Priv.-Doz.) analyse the findings of an exclusive 800+ healthcare professional primary research survey undertaken by IQVIA at the end of 2023 across the US, UK, Germany, France, Italy, and Spain, outlining the long term impact of the Pandemic on interaction levels, channels used to engage, and what healthcare professionals are seeking in terms of insight and information from pharmaceutical companies now and in the future. https://lnkd.in/eawxEb4g

The shift to precision medicine and hybrid engagement is reshaping expectations for how #medicalaffairs teams create value. This article explores: 📈 The key trends shaping medical affairs today 🎯 Where medical affairs should be focusing its strategic efforts 💡 Five foundational capabilities to offer precise impactful engagement 🏆 What are the critical success factors for medical value generation Read now https://bit.ly/4aM7nT8 #pharmaceuticals #medicalscienceliaison